+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of a malignant gastrointestinal stromal tumour with imatinib Morphology of regression, remission and recurrence



Treatment of a malignant gastrointestinal stromal tumour with imatinib Morphology of regression, remission and recurrence



Pathology Research & Practice 199(4): 231




(PDF emailed within 1 workday: $29.90)

Accession: 035980678

Download citation: RISBibTeXText


Related references

Complete remission of a metastatic gastrointestinal stromal tumour with the tyrosine kinase inhibitor imatinib (STI 571): effect of low dosage in an advanced tumour with exon 11 mutation. European Journal of Gastroenterology & Hepatology 15(3): 323-327, 2003

Flushing revealing the recurrence of a rectal gastrointestinal stromal tumour. Efficacy of imatinib. Gastroenterologie Clinique et Biologique 30(4): 636-637, 2006

Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones. Histopathology 49(1): 99-100, 2006

Imatinib in the treatment of gastrointestinal stromal tumour. Analytical Cellular Pathology 25(5-6): 229, 2003

Imatinib mesilate for the treatment of gastrointestinal stromal tumour. Expert Opinion on PharmacoTherapy 9(7): 1211-1222, 2008

Imatinib treatment for gastrointestinal stromal tumour (GIST). Journal of Cellular and Molecular Medicine 14(1-2): 42-50, 2011

Application of imatinib in treatment of gastrointestinal stromal tumour. Zhongguo Xinyao yu Linchuang Zazhi 23(11): 806-810, 2004

Imatinib mesylate in the treatment of gastrointestinal stromal tumour. Expert Opinion on PharmacoTherapy 6(1): 105-113, 2005

Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate. Tidsskrift for den Norske Laegeforening 125(7): 868-872, 2005

Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib. British Journal of Surgery 102(8): 965-971, 2015

Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case. Surgery Today 36(8): 727-732, 2006

DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour. Acta Oncologica 50(1): 148-150, 2011

Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour. Histopathology 46(4): 470-472, 2005

Recurrence after imatinib treatment for gastrointestinal stromal tumor: Japanese experience in a single institute. Journal of Clinical Oncology 24(18_suppl): 19504-19504, 2016

Long-term outcome of molecular subgroups of gastrointestinal stromal tumour patients treated with standard-dose imatinib in the BFR14 trial: The wild-type gastrointestinal stromal tumours are not a single group yet. European Journal of Cancer 58: 38-40, 2016